As part of its efforts to strengthen self-sufficiency and advance the national healthcare sector, Faruk Investment Group, through its specialised subsidiary Rasan Pharmaceutical Industries, continues to support national pharmaceutical security and reduce reliance on imports in the Kurdistan Region and Iraq.
Rasan Pharmaceutical is a pioneer in the production of high-quality intravenous (IV) solutions and sterile injectable medicines, catering to the needs of hospitals and healthcare centres, and contributing to closing the gap in the local supply of essential medicines.
Dr Abdulrazzaq Rahim, General Manager of the company, stated that the primary objective behind establishing Rasan is to localise pharmaceutical manufacturing and promote self-reliance in the healthcare sector by providing reliable pharmaceutical products that adhere to international quality standards.
The company is committed to implementing the latest global production standards and plays an active role in transferring and localising pharmaceutical technologies. It also takes pride in employing skilled Iraqi professionals to manufacture vital and strategic medicines—demonstrating its commitment to local development and sustainability.